Merck, known as MSD outside the U.S. and Canada, will present new clinical trial and outcomes research results at the European Society of Cardiology Congress (ESC) 2025 in Madrid, Spain, from August 29 – September 1. The statistics emphasize Merck’s
Abbott, a multinational healthcare corporation, introduced the FreeStyle Libre 2 Plus sensor, which provides automatic glucose readings every minute directly to a person's phone, enabling diabetics to confidently, accurately, and easily control their
It is a crucial step towards enhancing India’s global trade capabilities in the pharmaceutical and medical devices sectors.The Pharmaceuticals Export Promotion Council of India (Pharmexcil) participated in a high-level strategic meeting convened by
Thermo Fisher Scientific announced plans to make significant investments in India’s biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. The announcements came when senior executives addressed
.jpeg)
Alcon, the world leader in eye care, announced the commercial launch of its next-generation surgical platforms, the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) in India. The combined VCS console has been made a...
In a revolutionary stride that will change the landscape of cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to implement a deep learning based AI module for the identification of lymph node
Manufacturers are being obliged to destroy stocks in order to comply with a new rule by the Central Drugs Standard Control Organization (CDSCO) that prohibits the export of pharmaceutical items with a shelf life of less than 60%
With investments of over Rs. 54,000 crore in the last year alone, Telangana has once again established itself as a global leader in the life sciences, and the city is currently listed among the top 7 life sciences clusters worldwide
With a focus on finding new RNA-targeting small molecules in specific neurological indications with high unmet medical need, Skyhawk Therapeutics, a leader in the discovery and development of small molecules that modulate RNA expression, announces
Glenmark Pharmaceuticals Inc. is officially announced to implement the launch1 of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) from Glenmark Pharmaceuticals Inc., USA (Glenmark)
.jpg)
, CDSCO.jpg)